Zivo Bioscience, Inc.

ZIVOSEC EDGAR

Biological Products, (No Diagnostic Substances)(NV)CIK: 1101026

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue from Contract with Customer, Excluding Assessed Tax	$27.6K	$0.00	—	—	—
Cost of Goods and Services Sold	$16.0K	$0.00	—	—	—
Gross Profit	$11.6K	$0.00	—	—	—
Research and Development Expense	$1.4M	$2.2M	$2.0M	$3.8M	$2.3M
Operating Expenses	$7.3M	$8.7M	$8.6M	$8.6M	$8.4M
Operating Income (Loss)	-$7.3M	-$8.7M	-$8.6M	-$8.6M	-$8.4M
Interest Expense	—	$13.3K	$44.7K	$97.6K	—
Nonoperating Income (Expense)	—

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$555.7K	$2.1M	$9.0M	$220.2K	$369.4K
Assets, Current	$425.4K	$1.9M	$9.0M	$167.8K	$369.4K
Cash and Cash Equivalents, at Carrying Value	—	—	$137.9K	$346.1K	$388.9K
Inventory, Net	—	—	—	—	—
Liabilities	$2.8M	$2.1M	$2.9M	$11.5M	$8.7M
Liabilities, Current	$2.8M	$2.0M	$2.9M	$11.4M	$8.7M
Accounts Payable, Current	$993.1K	$490.7K	$654.3K	$1.6M	$1.4M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$5.8M	-$7.1M	-$6.8M	-$2.6M	-$3.7M
Net Cash Provided by (Used in) Investing Activities	$0.00	$0.00	$0.00	$0.00	$0.00
Net Cash Provided by (Used in) Financing Activities	$4.3M	$0.00	$15.6M	$2.4M	$3.7M
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)